Changes in the clinicopathological characteristics and outcomes of thyroid cancer in korea over the past four decades

Thyroid

Volumn 23, Issue 7, 2013, Pages 797-804

  Cho, Bo Youn ^a   Choi, Hoon Sung ^a   Park, Young Joo ^a   Lim, Jung Ah ^a   Ahn, Hwa Young ^a   Lee, Eun Kyung ^b   Kim, Kyung Won ^a   Yi, Ka Hee ^a   Chung, June Key ^a   Youn, Yeo Kyu ^a   Cho, Nam Han ^c   Park, Do Joon ^a   Koh, Chang Soon ^a  

^a Seoul National University   (South Korea)

^b National Cancer Center   (South Korea)

^c Ajou University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; KOREA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; THYROID CANCER; TUMOR VOLUME;

ADULT; CARCINOMA; CARCINOMA, PAPILLARY; FEMALE; HUMANS; INCIDENCE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROTO-ONCOGENE PROTEINS B-RAF; REPUBLIC OF KOREA; THYROID NEOPLASMS;

EID: 84877257366     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2012.0329     Document Type: Article

References (49)

1. Olaleye O, Ekrikpo U, Moorthy R, Lyne O, Wiseberg J, Black M, Mitchell D 2010 Increasing incidence of differentiated thyroid cancer in South East England: 1987-2006. Eur Arch Otorhinolaryngol 268:899-906
2. Machens A, Dralle H 2010 Decreasing tumor size of thyroid cancer in Germany: Institutional experience 1995-2009. Eur J Endocrinol 163:111-119
3. Kilfoy BA, Zheng T, Holford TR, Han X, Ward MH, Sjodin A, Zhang Y, Bai Y, Zhu C, Guo GL, Rothman N 2009 International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control 20:525-531
4. Enewold L, Zhu K, Ron E, Marrogi AJ, Stojadinovic A, Peoples GE, Devesa SS 2009 Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev 18:784-791
5. Davies L, Welch HG 2006 Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295:2164-2167
6. Aschebrook-Kilfoy B, Ward MH, Sabra MM, Devesa SS 2011 Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. Thyroid 21:125-134
7. Elisei R, Molinaro E, Agate L, Bottici V, Masserini L, Ceccarelli C, Lippi F, Grasso L, Basolo F, Bevilacqua G, Miccoli P, Di Coscio G, Vitti P, Pacini F, Pinchera A 2010 Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. J Clin Endocrinol Metab 95:1516-1527
8. Liu S, Semenciw R, Ugnat AM, Mao Y 2001 Increasing thyroid cancer incidence in Canada, 1970-1996: Time trends and age-period-cohort effects. Br J Cancer 85:1335-1339
9. Hughes DT, Haymart MR, Miller BS, Gauger PG, Doherty GM 2011 The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years. Thyroid 21:231-236
10. Reynolds RM, Weir J, Stockton DL, Brewster DH, Sandeep TC, Strachan MW 2005 Changing trends in incidence and mortality of thyroid cancer in Scotland. Clin Endocrinol (Oxf) 62:156-162
11. Leenhardt L, Grosclaude P, Cherie-Challine L 2004 Increased incidence of thyroid carcinoma in France: A true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid 14:1056-1060
12. Morris LG, Myssiorek D 2010 Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: A population-based analysis. Am J Surg 200: 454-461
13. Burgess JR, Tucker P 2006 Incidence trends for papillary thyroid carcinoma and their correlation with thyroid surgery and thyroid fine-needle aspirate cytology. Thyroid 16:47-53
14. Hayashi Y, Lagarde F, Tsuda N, Funamoto S, Preston DL, Koyama K, Mabuchi K, Ron E, Kodama K, Tokuoka S 2010 Papillary microcarcinoma of the thyroid among atomic bomb survivors: Tumor characteristics and radiation risk. Cancer 116:1646-1655
15. Rego-Iraeta A, Perez-Mendez LF, Mantinan B, Garcia-Mayor RV 2009 Time trends for thyroid cancer in northwestern Spain: True rise in the incidence of micro and larger forms of papillary thyroid carcinoma. Thyroid 19:333-340
16. Moradi T, Nordqvist T, Allebeck P, Galanti MR 2008 Risk of thyroid cancer among Iranian immigrants in Sweden. Cancer Causes Control 19:221-226
17. Jung KW, Park S, Kong HJ, Won YJ, Lee JY, Seo HG, Lee JS 2012 Cancer statistics in Korea: Incidence, mortality, survival, and prevalence in 2009. Cancer Res Treat 44:11-24
18. Kim JY, Moon SJ, Kim KR, Sohn CY, Oh JJ 1998 Dietary iodine intake and urinary iodine excretion in normal Korean adults. Yonsei Med J 39:355-362
19. Kim KH, Suh KS, Kang DW, Kang DY 2005 Mutations of the BRAF gene in papillary thyroid carcinoma and in Hashimoto's thyroiditis. Pathol Int 55:540-545
20. Jo YS, Li S, Song JH, Kwon KH, Lee JC, Rha SY, Lee HJ, Sul JY, Kweon GR, Ro HK, Kim JM, Shong M 2006 Influence of the BRAF V600E mutation on expression of vascular endothelial growth factor in papillary thyroid cancer. J Clin Endocrinol Metab 91:3667-3670
21. Lee JH, Lee ES, Kim YS, Won NH, Chae YS 2006 BRAF mutation and AKAP9 expression in sporadic papillary thyroid carcinomas. Pathology 38:201-204
22. Kim TH, Park YJ, Lim JA, Ahn HY, Lee EK, Lee YJ, Kim KW, Hahn SK, Youn YK, Kim KH, Cho BY, Park DJ 2012 The association of the BRAF (V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: A meta-analysis. Cancer 118:1764-1773
23. Park YJ, Ahn HY, Choi HS, Kim KW, Park DJ, Cho BY 2012 The long-term outcomes of the second generation of familial nonmedullary thyroid carcinoma are more aggressive than sporadic cases. Thyroid 22:356-362
24. Lorenzen J, Beese M, Mester J, Brumma K, Beyer W, Clausen M 1998 Chest X ray: Routine indication in the follow-up of differentiated thyroid cancer? Nuklearmedizin 37:208-212
25. Kim JY, Kim KR 2000 Dietary iodine intake and urinary iodine excretion in patients with thyroid diseases. Yonsei Med J 41:22-28
26. Farahati J, Geling M, Mader U, Mortl M, Luster M, Muller JG, Flentje M, Reiners C 2004 Changing trends of incidence and prognosis of thyroid carcinoma in lower Franconia, Germany, from 1981-1995. Thyroid 14:141-147
27. Pettersson B, Coleman MP, Ron E, Adami HO 1996 Iodine supplementation in Sweden and regional trends in thyroid cancer incidence by histopathologic type. Int J Cancer 65: 13-19
28. Kolonel LN, Hankin JH, Wilkens LR, Fukunaga FH, Hinds MW 1990 An epidemiologic study of thyroid cancer in Hawaii. Cancer Causes Control 1:223-234
29. Blomberg M, Feldt-Rasmussen U, Andersen K, Kjaer S 2012 Thyroid cancer in Denmark 1943-2008, before and after iodine supplementation. Int J Cancer 131:2360-2366
30. Bulow Pedersen I, Knudsen N, Carle A, Vejbjerg P, Jorgensen T, Perrild H, Ovesen L, Banke Rasmussen L, Laurberg P 2011 A cautious iodization program bringing iodine intake to a low recommended level is associated with an increase in the prevalence of thyroid autoantibodies in the population. Clin Endocrinol (Oxf) 75:120-126
31. Kim KW, Park YJ, Kim EH, Park SY, Park do J, Ahn SH, Jang HC, Cho BY 2011 Elevated risk of papillary thyroid cancer in Korean patients with Hashimoto's thyroiditis. Head Neck 33:691-695
32. Gul K, Dirikoc A, Kiyak G, Ersoy PE, Ugras NS, Ersoy R, Cakir B 2010 The association between thyroid carcinoma and Hashimoto's thyroiditis: The ultrasonographic and histopathologic characteristics of malignant nodules. Thyroid 20:873-878
33. Chow SM, Law SC, Au SK, Mang O, Yau S, Yuen KT, Lau WH 2003 Changes in clinical presentation, management and outcome in 1348 patients with differentiated thyroid carcinoma: Experience in a single institute in Hong Kong, 1960- 2000. Clin Oncol (R Coll Radiol) 15:329-336
34. Chun EJ, Jang SN, Cho SI, Cho Y, Moon OR 2007 Disparities in participation in health examination by socio-economic position among adult Seoul residents. J Prev Med Public Health 40:345-350
35. Korea Centers for Disease Control and Prevention 2010 Community Health Survey Report Steele SR, Martin MJ, Mullenix PS, Azarow KS, Andersen CA 2005 The significance of incidental thyroid abnormalities identified during carotid duplex ultrasonography. Arch Surg 140:981-985
36. Kim KH, Kang DW, Kim SH, Seong IO, Kang DY 2004 Mutations of the BRAF gene in papillary thyroid carcinoma in a Korean population. Yonsei Med J 45:818-821
37. Lee X, Gao M, Ji Y, Yu Y, Feng Y, Li Y, Zhang Y, Cheng W, Zhao W 2009 Analysis of differential BRAF (V600E) mutational status in high aggressive papillary thyroid microcarcinoma. Ann Surg Oncol 16:240-245
38. Puxeddu E, Moretti S, Elisei R, Romei C, Pascucci R, Martinelli M, Marino C, Avenia N, Rossi ED, Fadda G, Cavaliere A, Ribacchi R, Falorni A, Pontecorvi A, Pacini F, Pinchera A, Santeusanio F 2004 BRAF (V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas. J Clin Endocrinol Metab 89:2414-2420
39. Lee KC, Li C, Schneider EB, Wang Y, Somervell H, Krafft M, Umbricht CB, Zeiger MA 2012 Is BRAF mutation associated with lymph node metastasis in patients with papillary thyroid cancer? Surgery 152:977-983
40. Uchino S, Noguchi S, Kawamoto H, Yamashita H, Watanabe S, Shuto S 2002 Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population. World J Surg 26:897-902
41. Lee SH, Kim TY, Ryu J-S, Gong G, Kim WB, Kim SC, Hong S, Shong YK 2008 Trends analysis of characteristics of thyroid cancer patients in one medical center. J Kor Endocr Soc 23:35-43
42. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kodary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BK (eds) 2011 SEER Cancer Statistics Review, 1975-2008. National Cancer Institute, Bethesda, MD. http://seer.cancer. gov/csr/1975-2008/, (based on November 2010 SEER data submission).
43. Ott RA, McCall AR, McHenry C, Jarosz H, Armin A, Lawrence AM, Paloyan E 1987 The incidence of thyroid carcinoma in Hashimoto's thyroiditis. Am Surg 53:442-445
44. Okayasu I, Fujiwara M, Hara Y, Tanaka Y, Rose NR 1995 Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white and African Americans. Cancer 76:2312- 2318
45. Verkooijen HM, Fioretta G, Pache JC, Franceschi S, Raymond L, Schubert H, Bouchardy C 2003 Diagnostic changes as a reason for the increase in papillary thyroid cancer incidence in Geneva, Switzerland. Cancer Causes Control 14:13-17
46. Harach HR, Ceballos GA 2008 Thyroid cancer, thyroiditis and dietary iodine: A review based on the Salta, Argentina model. Endocr Pathol 19:209-220
47. Burgess JR, Dwyer T, McArdle K, Tucker P, Shugg D 2000 The changing incidence and spectrum of thyroid carcinoma in Tasmania (1978-1998) during a transition from iodine sufficiency to iodine deficiency. J Clin Endocrinol Metab 85:1513-1517
48. Kovacs GL, Gonda G, Vadasz G, Ludmany E, Uhrin K, Gorombey Z, Kovacs L, Hubina E, Bodo M, Goth MI, Szabolcs I 2005 Epidemiology of thyroid microcarcinoma found in autopsy series conducted in areas of different iodine intake. Thyroid 15:152-157
49. McLeod MK, East ME, Burney RE, Harness JK, Thompson NW 1988 Hashimoto's thyroiditis revisited: The association with thyroid cancer remains obscure. World J Surg 12:509- 516